Alkahest News and Activities

Alkahest is owned by Grifols.

Grifols is one of the...

• Fortune 500 Europe (#458);
• Stoxx 600;
• TOB Iconic 10,000.

Grifols is a company listed under the stock ticker GRFS (ES).

Grifols has a direct presence in 5 countries.

Grifols has 5 subsidiaries including Alkahest, Biotest and Biotest Austria.

They are in:

• Pharmaceuticals67%
• Biotechnology17%
• Other17%

View the org chart displaying its 12 main executives

Most searched biographies at Alkahest

• David Bell, Chairman of the Board
• Tony Wyss-Coray, Director
• Jaume Oliva, Director

Popular executive movements at Grifols

• Jörg Schuettrumpf, Chief Scientific Innovation officer, has left the company  (posted on April 7 2026).

Create your alert
to follow the executive moves at Alkahest.

Grifols has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Alkahest

• Publications & Presentations - Alkahest

Social media about Alkahest

• Alkahest on Wikipedia, Google News & Yahoo Finance
• Alkahest on LinkedIn, X (Twitter) & YouTube